Peptide record

TPDB02221

β-Casomorphin-5 Anticancer Antihypertensive Antioxidant Antiviral Blood-Brain Barrier Neuropeptide standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02221
β-Casomorphin-5
Anticancer Antihypertensive Antioxidant Antiviral Blood-Brain Barrier Neuropeptide
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Delivery and barrier-penetrating peptides Neuroactive peptides Functional / health-promoting peptides
AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF AnOxPePred - 1.0 AoXpDb Multi-AOP B3Pred BBPpredict
standard
No
A 5-aa standard-residue multi-activity (Anticancer, Antihypertensive, Antioxidant, and other sources) peptide sequence curated from AntiCP 2.0, CancerPPD 2.0, Peptipedia, and other sources, with an available 3D structural model.
Sequence
YPFPG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C30H37N5O7
ARNDCEQHILKMSTWV
P
579.65
5.94
0
0
2
-0
-0.76
-0.420
0.00
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
1490
2.57
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
0
L
0
K
0
M
1
F
2
P
0
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 2 S: 0 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
5 reviewed residue count
C30H37N5O7 sequence-only estimate (linear, free termini)
579.65 sequence-only estimate (linear, free termini)
5.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-0.76 sequence-only estimate (linear, free termini)
-0.420 sequence-only estimate (linear, free termini)
Linear Activity
Tyr-Pro-Phe-Pro-Gly Activity
O=C(NC(C(=O)NCC(=O)O)CC(C)C)C1NCCC1 Activity
Evidence Records 2 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
22.4 min

Assay & Model

Efflux study ICU
half life, brain

Source & Reference

NA
B3Pdb

Other

human,bovine
Saturable
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.031 min-1

Assay & Model

Efflux study ICU
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

human,bovine
Saturable
Direct iodination